Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients

Autor: Hugues Abriel, Heidi Fodstad, Saïd Bendahhou, Jacques Barhanin, Heikki Swan, Laurent Schild, Kimmo Kontula, Jean-Sébastien Rougier, Päivi J. Laitinen-Forsblom
Přispěvatelé: Biomedicum Helsinki and Department of Medicine, Institut de pharmacologie moléculaire et cellulaire (IPMC), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS), Department of Pharmacology and Toxicology, Université de Lausanne (UNIL), Service of Cardiology, University Hospital, Department of Cardiology
Rok vydání: 2006
Předmět:
Male
ERG1 Potassium Channel
Mutant
Muscle Proteins
030204 cardiovascular system & hematology
Compound heterozygosity
Sodium Channels
MESH: KCNQ1 Potassium Channel
Membrane Potentials
NAV1.5 Voltage-Gated Sodium Channel
0302 clinical medicine
Chlorocebus aethiops
MESH: Animals
Finland
MESH: Heterozygote
Genetics
0303 health sciences
biology
Genetic Carrier Screening
MESH: Finland
[SDV.BA]Life Sciences [q-bio]/Animal biology
General Medicine
3. Good health
MESH: COS Cells
Long QT Syndrome
Child
Preschool

COS Cells
KCNQ1 Potassium Channel
Mutation (genetic algorithm)
Female
Adult
Heterozygote
congenital
hereditary
and neonatal diseases and abnormalities

medicine.medical_specialty
MESH: Mutation
Long QT syndrome
hERG
MESH: Ether-A-Go-Go Potassium Channels
Transfection
QT interval
Sudden death
MESH: Sodium Channels
MESH: Muscle Proteins
03 medical and health sciences
Internal medicine
medicine
Animals
Humans
MESH: Membrane Potentials
[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

cardiovascular diseases
030304 developmental biology
[SDV.GEN]Life Sciences [q-bio]/Genetics
MESH: Humans
MESH: Heterozygote Detection
MESH: Long QT Syndrome
business.industry
MESH: Transfection
MESH: Child
Preschool

MESH: Adult
Heterozygote advantage
medicine.disease
MESH: Cercopithecus aethiops
Ether-A-Go-Go Potassium Channels
MESH: Male
Endocrinology
Mutation
biology.protein
business
MESH: Female
Zdroj: Annals of Medicine
Annals of Medicine, Taylor & Francis, 2006, 38 (4), pp.294-304. ⟨10.1080/07853890600756065⟩
ISSN: 1365-2060
0785-3890
DOI: 10.1080/07853890600756065
Popis: BACKGROUND: Mutations of at least six different genes have been found to cause long QT syndrome (LQTS), an inherited arrhythmic disorder characterized by a prolonged QT interval on the electrocardiogram (ECG), ventricular arrhythmias and risk of sudden death. AIM: The aims were to define the yet undetermined phenotypic characteristics of two founder mutations and to study clinical features in compound heterozygotes identified during the course of the study. METHODS: To maximize identification of the compound heterozygotes, we used an extended group of LQTS patients comprising 700 documented or suspected cases. Functional studies were carried out upon transient expression in COS-7 or HEK293 cells. RESULTS: The KCNQ1 IVS7-2A>G (KCNQ1-FinB) mutation associated with a mean QTc interval of 464 ms and a complete loss-of-channel function. The HERG R176W (HERG-FinB) mutation caused a reduction in current density as well as slight acceleration of the deactivation kinetics in vitro, and its carriers had a mean QTc of 448 ms. The HERG R176W mutation was also present in 3 (0.9%) out of 317 blood donors. A total of six compound heterozygotes were identified who had the HERG R176W mutation in combination with a previously reported LQTS mutation (KCNQ1 G589D or IVS7-2A>G). When present simultaneously with an apparent LQTS-causing mutation, the HERG R176W mutation may exert an additional in vivo phenotypic effect. CONCLUSIONS: The HERG R176W mutation represents a population-prevalent mutation predisposing to LQTS. Compound heterozygosity for mutant LQTS genes may modify the clinical picture in LQTS.
Databáze: OpenAIRE